These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10321437)

  • 1. Prevention of coronary heart disease in clinical practice. Summary of recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention.
    Wood D; De Backer G; Faergeman O; Graham I; Mancia G; Pyörälä K
    Blood Press; 1998 Nov; 7(5-6):262-9. PubMed ID: 10321437
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of coronary heart disease in clinical practice. Summary of recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention.
    Wood D; De Backer G; Faergeman O; Graham I; Mancia G; Pyörälä K
    J Hypertens; 1998 Oct; 16(10):1407-14. PubMed ID: 9814610
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention.
    Wood D; De Backer G; Faergeman O; Graham I; Mancia G; Pyörälä K
    Atherosclerosis; 1998 Oct; 140(2):199-270. PubMed ID: 9862269
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention.
    Eur Heart J; 1998 Oct; 19(10):1434-503. PubMed ID: 9820987
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prevention of coronary disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology (ESC), European Atherosclerosis Society (EAS) and European Society of Hypertension (ESH)].
    de Backer G; Graham I; Poole-Wilson P; Pyörälä K; Shepherd J; Wood D; Zanchetti A
    Rev Esp Cardiol; 1995 Dec; 48(12):773-80. PubMed ID: 8685497
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prevention of coronary disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension].
    Pyörälä K; De Backer G; Graham I; Poole-Wilson P; Wood D; Force T
    Cardiologia; 1996 Feb; 41(2):149-82. PubMed ID: 8674094
    [No Abstract]   [Full Text] [Related]  

  • 7. [The prevention of coronary disease in clinical practice. The recommendations of the Second Joint Task Force of European Societies on the Prevention of Coronary Pathology. Società Europea di Cardiologia, Società Europea dell'Aterosclerosi, Società Europea dell'Ipertensione].
    Wood D; De Backer G; Faergeman O; Graham I; Mancia G; Pyörälä K
    Ital Heart J Suppl; 2000 May; 1(5):692-8. PubMed ID: 10834137
    [No Abstract]   [Full Text] [Related]  

  • 8. [Joint recommendations of Israel medical societies for prevention of coronary heart disease and atherosclerosis].
    Harats D; Rubinstein A
    Harefuah; 2000 Jan; 138(1):66-74. PubMed ID: 10868184
    [No Abstract]   [Full Text] [Related]  

  • 9. The child is father of the man.
    Glueck CJ
    Pediatrics; 1986 Aug; 78(2):364-8. PubMed ID: 3526271
    [No Abstract]   [Full Text] [Related]  

  • 10. Coronary heart disease: reducing the risk: a worldwide view. International Task Force for the Prevention of Coronary Heart Disease.
    Assmann G; Carmena R; Cullen P; Fruchart JC; Jossa F; Lewis B; Mancini M; Paoletti R
    Circulation; 1999 Nov; 100(18):1930-8. PubMed ID: 10545439
    [No Abstract]   [Full Text] [Related]  

  • 11. EUROASPIRE. A European Society of Cardiology survey of secondary prevention of coronary heart disease: principal results. EUROASPIRE Study Group. European Action on Secondary Prevention through Intervention to Reduce Events.
    Eur Heart J; 1997 Oct; 18(10):1569-82. PubMed ID: 9347267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategy, yield and risks of controlling plasma lipids in the primary prevention of coronary heart disease.
    Oliver MF
    Adv Exp Med Biol; 1985; 183():225-40. PubMed ID: 3898747
    [No Abstract]   [Full Text] [Related]  

  • 13. Summary and recommendations of the Conference on Blood Lipids in Children: optimal levels for early prevention of coronary artery disease. American Heart Foundation, April 18 and 19, 1983.
    Prev Med; 1983 Nov; 12(6):728-40. PubMed ID: 6676727
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prevention of coronary heart diseases in clinical practice. Comment on the recommendations of the Second Joint Task Force of European Societies for Prevention of Coronary Disease].
    Klein W; Maurer G; Patsch JR; Sandhofer F; Silberbauer K
    Wien Med Wochenschr; 1999; 149(5-6):111-8. PubMed ID: 10408001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Is treatment of metabolic factors a valid method in the control of arteriosclerosis and coronary disease?].
    Avogaro P
    Clin Ter; 1984 Oct; 111(1):15-9. PubMed ID: 6238776
    [No Abstract]   [Full Text] [Related]  

  • 16. [The strategy in the prevention of ischemic heart disease--European guidelines].
    Olsson AG
    Lakartidningen; 1987 Feb; 84(7):464-7. PubMed ID: 3561111
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevention of coronary heart disease should start early.
    Danilevicius Z
    JAMA; 1972 Oct; 222(4):484. PubMed ID: 4677836
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prevention of arteriosclerotic heart and vascular diseases].
    Siedek H
    Wien Med Wochenschr; 1971 Jul; 121(30):575-81. PubMed ID: 5564652
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, The European Atherosclerosis Society and the European Hypertension Society. A short overview for general practitioners].
    Pyörälä K; De Backer G; Graham I; Poole-Wilson P; Wood D
    Lijec Vjesn; 1996 Oct; 118(10):220-6. PubMed ID: 9132519
    [No Abstract]   [Full Text] [Related]  

  • 20. Guidelines--a missed opportunity.
    Wood D
    Atherosclerosis; 1999 May; 143 Suppl 1():S7-12. PubMed ID: 10382832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.